Reduced Birc6/Pten correlated with increasing severity of the pathology reflected by NAFLD Activity Scores (NAS) (Fig. 8H, I), clinically validating our murine model and confirming cross-species conservation of the BRUCE/PTEN-STAT3 axis in MASH progression. This evidence concerns the gene BIRC6 and metabolic dysfunction-associated steatotic liver disease.